Deutsch English Français

Contact

EP0808364

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP0808364

EP0808364 - HUMAN PANCREATIC CELL LINES: DEVELOPMENTS AND USES [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 06.10.2006 Database last updated on 26.06.2024
Most recent event Tooltip	04.01.2008	Lapse of the patent in a contracting state New state(s): IT	published on 06.02.2008 [2008/06]
Applicant(s)	For all designated states The Regents of the University of California 1111 Franklin Street, 12th Floor Oakland, CA 94607 / US
	[N/P]
Former [2005/48]	For all designated states The Regents of the University of California 1111 Franklin Street, 12th Floor Oakland CA 94607-5200 / US
Former [1999/49]	For all designated states The Regents of the University of California 1111 Franklin Street, 12th Floor Oakland, CA 94607-5200 / US
Former [1997/48]	For all designated states THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 300 Lakeside Drive, 22nd Floor Oakland, California 94612-3550 / US
Inventor(s)	01 / LEVINE, Fred 2427 Malibu Way Del Mar, CA 92014 / US
	02 / WANG, Sijian 8008 Avenue Navidad 55 San Diego, CA 92122 / US
	03 / BEATTIE, Gillian, M. 13615 Sagewood Drive Poway, CA 92064 / US
	04 / HAYEK, Alberto 8821 Nortingham Place La Jolla, CA 92037 / US
	[1997/48]
Representative(s)	Campbell, Patrick John Henry, et al J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB
	[N/P]
Former [2003/47]	Campbell, Patrick John Henry, et al J.A. Kemp & Co., 14 South Square, Gray's Inn London WC1R 5JJ / GB
Former [1997/48]	Goldin, Douglas Michael, et al J.A. KEMP & CO. 14 South Square Gray's Inn London WC1R 5LX / GB
Application number, filing date	96903692.0	25.01.1996
	[1997/48]
	WO1996US01055
Priority number, date	US19950386897	10.02.1995 Original published format: US 386897
	US19950509121	31.07.1995 Original published format: US 509121
	[1997/48]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9624669
	Date:	15.08.1996
	Language:	EN
	[1996/37]
	Type:	A1 Application with search report
	No.:	EP0808364
	Date:	26.11.1997
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 15.08.1996 takes the place of the publication of the European patent application.
	[1997/48]
	Type:	B1 Patent specification
	No.:	EP0808364
	Date:	30.11.2005
	Language:	EN
	[2005/48]
Search report(s)	International search report - published on:	US	15.08.1996
	(Supplementary) European search report - dispatched on:	EP	18.01.2001
Classification	IPC:	C12N15/86, C12N15/63, C12N7/01, C12N5/10, C07K14/82, C07K14/62, A61K48/00	[2001/10]
	CPC:	C12N15/86 (EP,US); A61P3/08 (EP); C07K14/62 (EP,US); C07K14/82 (EP,US); C12N5/0676 (EP,US); A61K38/00 (EP,US); (+) A61K48/00 (EP,US); C12N2501/12 (EP,US); C12N2510/04 (EP,US); C12N2740/13043 (EP,US); C12N2830/002 (EP,US); C12N2830/15 (EP,US); C12N2830/55 (EP,US); C12N2840/20 (EP,US); C12N2840/206 (EP,US) (-)
	Former IPC [1997/48]	C12N15/00, A61K48/00
Designated contracting states	AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1997/48]
Title	German:	MENSCHLICHE PANCREAS ZELLINIEN: ENTWICKLUNGEN UND ANWENDUNGEN	[2005/25]
	English:	HUMAN PANCREATIC CELL LINES: DEVELOPMENTS AND USES	[1997/48]
	French:	LIGNEES DE CELLULES PANCREATIQUES HUMAINES: DEVELOPPEMENTS ET UTILISATIONS	[1997/48]
	Former [1997/48]	MENSCHLICHE PANCREAS ZELLINIEN: ENTWIKLUNGEN UND ANWENDUNGEN
Biological material	This application mentions deposited biological material, check the file for details
Entry into regional phase	28.08.1997	National basic fee paid
	28.08.1997	Search fee paid
	28.08.1997	Designation fee(s) paid
	28.08.1997	Examination fee paid
Examination procedure	05.09.1996	Request for preliminary examination filed International Preliminary Examining Authority: US
	28.08.1997	Examination requested [1997/48]
	18.02.2002	Despatch of a communication from the examining division (Time limit: M06)
	30.09.2002	Reply to a communication from the examining division
	04.10.2002	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
	15.05.2003	Despatch of a communication from the examining division (Time limit: M04)
	23.09.2003	Reply to a communication from the examining division
	25.11.2003	Despatch of a communication from the examining division (Time limit: M04)
	05.02.2004	Reply to a communication from the examining division
	25.05.2005	Communication of intention to grant the patent
	29.09.2005	Fee for grant paid
	29.09.2005	Fee for publishing/printing paid
Divisional application(s)	EP05022650.5 / EP1616960
Opposition(s)	31.08.2006	No opposition filed within time limit [2006/45]
Request for further processing for:	30.09.2002	Request for further processing filed
	30.09.2002	Full payment received (date of receipt of payment) Request granted
	14.10.2002	Decision despatched
Fees paid	Renewal fee
	22.12.1997	Renewal fee patent year 03
	05.01.1999	Renewal fee patent year 04
	05.01.2000	Renewal fee patent year 05
	04.01.2001	Renewal fee patent year 06
	21.01.2002	Renewal fee patent year 07
	20.01.2003	Renewal fee patent year 08
	26.01.2004	Renewal fee patent year 09
	20.01.2005	Renewal fee patent year 10
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	AT	30.11.2005
	BE	30.11.2005
	DK	30.11.2005
	IT	30.11.2005
	NL	30.11.2005
	GR	28.02.2006
	SE	28.02.2006
	ES	13.03.2006
	PT	02.05.2006
	[2008/06]
Former [2006/49]	AT	30.11.2005
	BE	30.11.2005
	DK	30.11.2005
	NL	30.11.2005
	GR	28.02.2006
	SE	28.02.2006
	ES	13.03.2006
	PT	02.05.2006
Former [2006/39]	AT	30.11.2005
	BE	30.11.2005
	DK	30.11.2005
	NL	30.11.2005
	GR	28.02.2006
	SE	28.02.2006
	ES	13.03.2006
Former [2006/38]	AT	30.11.2005
	BE	30.11.2005
	NL	30.11.2005
	DK	28.02.2006
	GR	28.02.2006
	SE	28.02.2006
	ES	13.03.2006
Former [2006/36]	AT	30.11.2005
	BE	30.11.2005
	NL	30.11.2005
	DK	28.02.2006
	SE	28.02.2006
	ES	13.03.2006
Former [2006/34]	AT	30.11.2005
	NL	30.11.2005
	DK	28.02.2006
	SE	28.02.2006
	ES	13.03.2006
Former [2006/33]	NL	30.11.2005
	SE	28.02.2006
	ES	13.03.2006
Former [2006/27]	NL	30.11.2005
	SE	28.02.2006
Former [2006/24]	NL	30.11.2005
Documents cited:	Search	[Y]WO8903882 (IMMUNEX CORP [US]) [Y] 1-19,27,28 * the whole document *;
		[A]WO8903872 (AMRAD CORP LTD [AU]) [A] * the whole document *;
		[A]EP0332416 (DANA FARBER CANCER INST INC [US]) [A] * the whole document *;
		[A]WO9112329 (UNIV TEXAS [US]) [A] * claims 1-33 *;
		[A]EP0455424 (MERCK & CO INC [US]) [A] * the whole document *;
		[A]WO9428113 (BIOTOP S A S DI RITA CASSARIN [IT], et al) [A] * the whole document *
	International search	[Y]WO9109939 (FELDMANN MARC [GB], et al);
		[YP]WO9529989 (US HEALTH [US], et al)
		[Y] - PROC. NATL. ACAD. SCI. U.S.A., December 1988, Vol. 85, EFRAT et al., "Beta-Cell Lines Derived from Transgenic Mice Expressing a Hybrid Insulin Gene-Oncogene", pages 9037-9041.
		[Y] - CANCER RESEARCH, 15 February 1992, Vol. 52, LIU et al., "Control of Ha-Ras-Mediated Mammalian Cell Transformation by Escherichia Coli Regulatory Elements", pages 983-989.
		[YP] - PROC. NATL. ACAD. SCI. U.S.A., April 1995, Vol. 92, EFRAT et al., "Conditional Transformation of a Pancreatic B-Cell Line Derived from Transgenic Mice Expressing a Tetracycline-Regulated Oncogene", pages 3576-3580.
		[YP] - J. CELLULAR BIOCHEMISTRY SUPPLEMENT, 1995, Vol. 21B, EFRAT et al., "Development of Correctly-Regulated Pancreatic B-Cell Lines", page 4.
		[Y] - ONCOLOGY REPORTS, 1994, Vol. 1, LILOGLOU et al., "Inducible H-Ras Gene Expression Controlled by an Allosterically Regulated Transactivator", pages 889-893.
		[Y] - PROC. AM. ASSOC. CANCER RESEARCH ANNUAL MEETING, 1995, Vol. 36, WANG et al., "Establishment of Human Fetal Pancreatic Cell Lines by a Retroviral Vector Which Contains SV40 T-Antigen", page 182.
		[Y] - J. AUTOIMMUNITY, 1991, Vol. 4, SOLDEVILA et al., "Transfection with SV40 Gene of Human Pancreatic Endocrine Cells", pages 381-396.
		[Y] - MOLECULAR ENDOCRINOLOGY, 1989, Vol. 3, No. 10, CHOU J.Y., "Differentiated Mammalian Cell Lines Immortalized by Temperature-Sensitive Tumor Viruses", pages 1511-1514.
	Examination	- LARSEN, J. ET AL., "The v-ski oncogene cooperates with the v-sea oncogene in erythroid transformation by blocking erythroid differentiation.", ONCOGENE, (1992), vol. 7, no. 10, pages 1903 - 1911
		- ROSEN, C.A. ET AL., "Construction of recombinant murine retroviruses that express the human T-cell leukeima virus type II and human T-cell lymphotropic cirus type III trans activator genes.", J.VIROL., (1986), vol. 57, no. 1, pages 379 - 384
		- SOLDEVILA, G. ET AL., "Transfection with SV40 gene of human pancreatic endocriene cells.", J.AUTOIMMUNOLOGY, (1991), vol. 4, no. 3, pages 381 - 396
		- LARSEN J. ET AL, "The v-ski oncogene cooperates with the v-sea oncogene in erythroid transformation by blocking erythroid differentiation.", ONCOGENE, (1992), vol. 7, no. 10, pages 1903 - 1911

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p